Mitsubishi UFJ Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35M | Buy |
159,856
+16,971
| +12% | +$3.71M | 0.03% | 416 |
|
|
2025
Q1 | $32M | Buy |
142,885
+14,207
| +11% | +$3.18M | 0.03% | 414 |
|
|
2024
Q4 | $43.2M | Buy |
128,678
+4,699
| +4% | +$1.58M | 0.04% | 331 |
|
|
2024
Q3 | $37.2M | Buy |
123,979
+12,182
| +11% | +$3.66M | 0.04% | 346 |
|
|
2024
Q2 | $36.8M | Buy |
111,797
+5,799
| +5% | +$1.91M | 0.04% | 316 |
|
|
2024
Q1 | $41.9M | Buy |
105,998
+19,626
| +23% | +$7.77M | 0.06% | 271 |
|
|
2023
Q4 | $29.2M | Sell |
86,372
-326
| -0.4% | -$110K | 0.05% | 298 |
|
|
2023
Q3 | $32.5M | Buy |
86,698
+3,911
| +5% | +$1.47M | 0.07% | 249 |
|
|
2023
Q2 | $31.7M | Sell |
82,787
-2,690
| -3% | -$1.03M | 0.07% | 241 |
|
|
2023
Q1 | $29.6M | Buy |
85,477
+3,447
| +4% | +$1.19M | 0.07% | 235 |
|
|
2022
Q4 | $19.2M | Buy |
82,030
+11,221
| +16% | +$2.63M | 0.05% | 298 |
|
|
2022
Q3 | $17.4M | Buy |
70,809
+16,029
| +29% | +$3.94M | 0.06% | 285 |
|
|
2022
Q2 | $16.6M | Buy |
54,780
+2,671
| +5% | +$808K | 0.07% | 275 |
|
|
2022
Q1 | $21.4M | Buy |
52,109
+4,109
| +9% | +$1.69M | 0.08% | 234 |
|
|
2021
Q4 | $21.4M | Buy |
48,000
+1,806
| +4% | +$805K | 0.09% | 237 |
|
|
2021
Q3 | $19.6M | Sell |
46,194
-915
| -2% | -$388K | 0.1% | 215 |
|
|
2021
Q2 | $16.9M | Buy |
47,109
+1,582
| +3% | +$568K | 0.09% | 231 |
|
|
2021
Q1 | $12.8M | Buy |
45,527
+24,425
| +116% | +$6.88M | 0.08% | 255 |
|
|
2020
Q4 | $5.98M | Buy |
21,102
+829
| +4% | +$235K | 0.05% | 399 |
|
|
2020
Q3 | $5.57M | Buy |
20,273
+3,215
| +19% | +$884K | 0.05% | 359 |
|
|
2020
Q2 | $3.88M | Buy |
17,058
+6,123
| +56% | +$1.39M | 0.04% | 387 |
|
|
2020
Q1 | $1.67M | Sell |
10,935
-986
| -8% | -$150K | 0.03% | 504 |
|
|
2019
Q4 | $1.81M | Buy |
+11,921
| New | +$1.81M | 0.02% | 560 |
|